Nichols E, Steinmetz JD, Vollset SE et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health 7:e105–e125. https://doi.org/10.1016/S2468-2667(21)00249-8
Montine TJ, Phelps CH, Beach TG et al (2012) National institute on aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathol 123:1–11. https://doi.org/10.1007/s00401-011-0910-3
Article CAS PubMed Google Scholar
Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800. https://doi.org/10.1212/WNL.58.12.1791
Braak H, Alafuzoff I, Arzberger T et al (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404. https://doi.org/10.1007/s00401-006-0127-z
Article PubMed Central PubMed Google Scholar
Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486
Article CAS PubMed Google Scholar
Nelson PT, Lee EB, Cykowski MD et al (2022) LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathologica 145(2):159–173. https://doi.org/10.1007/S00401-022-02524-2
Article PubMed Central PubMed Google Scholar
Nelson PT, Dickson DW, Trojanowski JQ et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report. Brain 142:1503–1527
Article PubMed Central PubMed Google Scholar
Kovacs GG, Ferrer I, Grinberg LT et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87–102. https://doi.org/10.1007/s00401-015-1509-x
Article CAS PubMed Google Scholar
Saito Y, Ruberu NN, Sawabe M et al (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911–918
Robinson JL, Corrada MM, Kovacs GG et al (2018) Non-Alzheimer’s contributions to dementia and cognitive resilience in the 90+ study. Acta Neuropathol 136:377–388. https://doi.org/10.1007/s00401-018-1872-5
Article PubMed Central PubMed Google Scholar
Montine TJ, Corrada MM, Kawas C et al (2022) Association of cognition and dementia with neuropathologic changes of Alzheimer disease and other conditions in the oldest old. Neurology 99:e1067. https://doi.org/10.1212/WNL.0000000000200832
Article PubMed Central PubMed Google Scholar
Kovacs GG (2019) Molecular pathology of neurodegenerative diseases: Principles and practice. J Clin Pathol 72:725–735. https://doi.org/10.1136/jclinpath-2019-205952
Article CAS PubMed Google Scholar
Flanagan ME, Marshall DA, Shofer JB et al (2017) Performance of a condensed protocol that reduces effort and cost of NIA-AA guidelines for neuropathologic assessment of Alzheimer disease. J Neuropathol Exp Neurol 76:39–43. https://doi.org/10.1093/jnen/nlw104
Article CAS PubMed Central PubMed Google Scholar
Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211. https://doi.org/10.1016/S0197-4580(02)00065-9
Attems J, Toledo JB, Walker L et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141:159–172. https://doi.org/10.1007/s00401-020-02255-2
Article CAS PubMed Central PubMed Google Scholar
McKeith I, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies. Fourth consensus of the DLB consortium. Neurology 89:88–100. https://doi.org/10.1212/01.wnl.0000187889.17253.b1
Article PubMed Central PubMed Google Scholar
Members of Hospital Clinic Barcelona Ethics Committee (2022) Ethics committee hospital clinic Barcelona. Reg. HCB/2022/1191. Barcelona
Crary JF, Trojanowski JQ, Schneider JA et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755–766. https://doi.org/10.1007/s00401-014-1349-0
Article CAS PubMed Central PubMed Google Scholar
Kovacs GG, Lukic MJ, Irwin DJ et al (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99–119. https://doi.org/10.1007/s00401-020-02158-2
Article PubMed Central PubMed Google Scholar
Roemer SF, Grinberg LT, Crary JF et al (2022) Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol 144:603–614. https://doi.org/10.1007/s00401-022-02479-4
Article CAS PubMed Central PubMed Google Scholar
Kovacs GG, Xie SX, Robinson JL et al (2018) Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain. Acta Neuropathol Commun 6:50. https://doi.org/10.1186/s40478-018-0552-y
Article CAS PubMed Central PubMed Google Scholar
Ferrer I, Santpere G, Van Leeuwen FW (2008) Argyrophilic grain disease. Brain 131:1416–1432. https://doi.org/10.1093/brain/awm305
Höglinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord 32:853–864. https://doi.org/10.1002/mds.26987
Article PubMed Central PubMed Google Scholar
Boxer AL, Yu JT, Golbe LI et al (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16:552–563. https://doi.org/10.1016/S1474-4422(17)30157-6
Article PubMed Central PubMed Google Scholar
Driver-Dunckley ED, Zhang N, Serrano GE et al (2023) Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy. J Neuropathol Exp Neurol 82:438–451. https://doi.org/10.1093/JNEN/NLAD025
Multz RA, Spencer C, Matos A et al (2023) What every neuropathologist needs to know: condensed protocol work-up for clinical dementia syndromes. J Neuropathol Exp Neurol 82:103–109. https://doi.org/10.1093/JNEN/NLAC114
Article CAS PubMed Google Scholar
Dickson DW, Bergeron C, Chin SS et al (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946. https://doi.org/10.1093/jnen/61.11.935
Article CAS PubMed Google Scholar
Mckee AC, Stein TD, Kiernan PT et al (2016) The neuropathologyof chornic traumatic encephalopathy. Brain Pathol 25:350–364. https://doi.org/10.1111/bpa.12248.The
Bieniek KF, Cairns NJ, Crary JF et al (2021) The second NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. J Neuropathol Exp Neurol 80:210–219. https://doi.org/10.1093/jnen/nlab001
Article CAS PubMed Central PubMed Google Scholar
Lee EB, Porta S, Michael Baer G et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65–78. https://doi.org/10.1007/s00401-017-1679-9
Article CAS PubMed Central PubMed Google Scholar
Mackenzie IRA, Neumann M, Baborie A et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111–113. https://doi.org/10.1007/s00401-011-0845-8
Article PubMed Central PubMed Google Scholar
Brettschneider J, Del Tredici K, Irwin DJ et al (2014) Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 127:423–439. https://doi.org/10.1007/s00401-013-1238-y
Article CAS PubMed Central PubMed Google Scholar
Brettschneider J, Del Tredici K, Toledo JB et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20–38. https://doi.org/10.1002/ana.23937
Article CAS PubMed Central PubMed Google Scholar
Maioli H, Mittenzwei R, Shofer JB et al (2023) Performance of a condensed protocol to assess limbic-predominant age-related TDP-43 encephalopathy neuropathologic change. J Neuropathol Exp Neurol. https://doi.org/10.1093/jnen/nlad035
Kalaria RN (2016) Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease. Acta Neuropathol 131:659–685
Comments (0)